Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations.

Brain tumor pathology - 1 Jan 2017

Ogishima Takahiro, Tamura Kaoru, Kobayashi Daisuke, Inaji Motoki, Hayashi Shihori, Tamura Reina, Nariai Tadashi, Ishii Kenji, Maehara Taketoshi

Abstract excerpt

Recent studies on gliomas have shown frequent alterations in the alpha-thalassemia/mental retardation syndrome X-linked gene (ATRX). This study was designed to determine whether ATRX status correlates with uptake of 11C-methionine in WHO grades II and III gliomas. Sixty-two patients underwent 11C-methionine positron emission tomography scans prior to histological diagnosis. The tumor-to-normal ratio (T/N) of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Methionine

Share to Neoplasm Grading

Share to X-linked Nuclear Protein

Source

Identifiers

PMID: 28251430
DOI: 10.1007/s10014-017-0280-1

Genes

ATRX
IDH1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations.PMID 28251430Read ↗

Molecular Classification Defines 4 Prognostically Distinct Glioma Groups Irrespective of Diagnosis and GradeSemantic proximity Read ↗

New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.Semantic proximity Read ↗

Incidence of biomarkers in high-grade gliomas and their impact on survival in a diverse SouthEast Asian cohort - a population-based study.Semantic proximity Read ↗

Immunohistochemical Expression of IDH1, ATRX, Ki67, GFAP, and Prognosis in Indonesian Glioma PatientsSemantic proximity Read ↗

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.Semantic proximity Read ↗

ATRX immunostaining predicts IDH and H3F3A status in gliomasSemantic proximity Read ↗

Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade GliomaSemantic proximity Read ↗

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.Semantic proximity Read ↗

Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas.Semantic proximity Read ↗

Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates.Semantic proximity Read ↗

A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.Semantic proximity Read ↗

Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.